# Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization

> **NCT01449539** · NA · TERMINATED · sponsor: **University of Arkansas** · enrollment: 8 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Hyperbaric Oxygen Therapy

## Key facts

- **NCT ID:** NCT01449539
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Study was terminated early because the site that administered the hyperbaric oxygen treatment closed and an alternative site could not be identified.
- **Last updated:** 2015-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449539, "Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT01449539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*